Lymphocytes in early atherogenesis

July 11, 2001

In addition to their characteristic accumulation of macrophage-derived foam cells and proliferation of smooth muscle cells, atherosclerotic lesions contain T lymphocytes, predominantly of the Th1 class. Despite some evidence that these cells respond to epitopes that are found in the lesion, their role, if any, in the disease process has been hard to pin down. Song et al. have now revisited this question by following lesion progression in the atherosclerosis-prone LDLR-/- mouse strain, comparing LDLR-/-animals, which have a full complement of lymphocytes, with littermates of the double knockout genotype LDLR-/- RAG1-/- , which are devoid of B and T lymphocytes. The presence or absence of lymphocytes does not affect the ultimate outcome of feeding these mice a cholesterol-rich diet, but the authors find that the early events of lesion growth are slowed in double knockout mice. These findings are at odds with some earlier studies that examined the role of lymphocytes in pathogenesis in the ApoE-deficient strain, another widely studied atherosclerosis-prone model. Song et al. argue that their system more accurately matches human pathogenesis, in part because ApoE-deficiency (but not LDLR-deficiency) leads to impaired innate immune responses, a change that is not seen in humans with heart disease. Since RAG1-/- mice lack all lymphocytes, it will be important to examine the specific contributions of Th1 cells and other lymphocyte subtypes to this disease process.

JCI Journals

Related Lymphocytes Articles from Brightsurf:

Multiple sclerosis as the flip side of immune fitness
About half of the people with multiple sclerosis have the HLA-DR15 gene variant.

'Multi-omics' adds new cell to immune family tree
Australian researchers have used powerful 'single cell multi-omics' technologies to discover a previously unknown ancestor of T and B lymphocytes, which are critical components of our immune system.

New study suggests crucial role for lymphocytes in asymptomatic COVID-19 infection
A retrospective study of 52 COVID-19 patients, published this week in mSphere, an open-access journal of the American Society for Microbiology, may help researchers better understand why not everyone show symptoms of the disease.

The number and clonality of TCRs are associated with the prognosis of colorectal cancer
This study has used a new technique called 'T-cell receptor (TCR) immuno-sequencing', which allows us to obtain both the number of T lymphocytes that infiltrate the tumor and their clonality index.

The behavior of therapeutic antibodies in immunotherapy
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells.

Cell competition in the thymus is crucial in a healthy organism
The study published in Cell Reports demonstrates that the development of T lymphocytes lays on the coordination of signals followed by cells in order to ensure the maintenance of a healthy organism.

Scientists explore using 'own' immune cells to target infectious diseases including COVID-19
The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School, as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2.

Cancer: The immune system attacks tumors remotely
How does the immune system act to limit tumor development?

Discovered a new process of antitumor response of NK cells in myeloma
The stem cell transplant and cell immunotherapy group of the Josep Carreras Leukemia Research Institute reveals how NK cells activate a set of actions that promote their antitumor capacity in the presence of myeloma cells.

From sleeping cell to assassin -- how immune cells work
Scientists at the University of Dundee have carried out one of the most comprehensive studies into how immune cells sense and respond to their environment to fight infection and destroy tumours.

Read More: Lymphocytes News and Lymphocytes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to